title: Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.
abstract: BACKGROUND
  A phased introduction of a monovalent rotavirus vaccine occurred in Mexico from February 2006 through May 2007. We assessed the effect of vaccination on deaths from diarrhea in Mexican children in 2008 and 2009.
  
  
  METHODS
  We obtained data on deaths from diarrhea, regardless of cause, from January 2003 through May 2009 in Mexican children under 5 years of age. We compared diarrhea-related mortality in 2008 and during the 2008 and 2009 rotavirus seasons with the mortality at baseline (2003-2006), before the introduction of the rotavirus vaccine. Vaccine coverage was estimated from administrative data.
  
  
  RESULTS
  By December 2007, an estimated 74% of children who were 11 months of age or younger had received one dose of rotavirus vaccine. In 2008, there were 1118 diarrhea-related deaths among children younger than 5 years of age, a reduction of 675 from the annual median of 1793 deaths during the 2003-2006 period. Diarrhea-related mortality fell from an annual median of 18.1 deaths per 100,000 children at baseline to 11.8 per 100,000 children in 2008 (rate reduction, 35%; 95% confidence interval [CI], 29 to 39; P<0.001). Among infants who were 11 months of age or younger, diarrhea-related mortality fell from 61.5 deaths per 100,000 children at baseline to 36.0 per 100,000 children in 2008 (rate reduction, 41%; 95% CI, 36 to 47; P<0.001). As compared with baseline, diarrhea-related mortality was 29% lower for children between the ages of 12 and 23 months, few of whom were age-eligible for vaccination. Mortality among unvaccinated children between the ages of 24 and 59 months was not significantly reduced. The reduction in the number of diarrhea-related deaths persisted through two full rotavirus seasons (2008 and 2009).
  
  
  CONCLUSIONS
  After the introduction of a rotavirus vaccine, a significant decline in diarrhea-related deaths among Mexican children was observed, suggesting a potential benefit from rotavirus vaccination.
authors.affiliation: National Center for Child and Adolescent Health, Ministry of Health, Mexico City.
authors.forename: Vesta
authors.initials: V
authors.lastname: Richardson
authors.forename: Joselito
authors.initials: J
authors.lastname: Hernandez-Pichardo
authors.forename: Manjari
authors.initials: M
authors.lastname: Quintanar-Solares
authors.forename: Marcelino
authors.initials: M
authors.lastname: Esparza-Aguilar
authors.forename: Brian
authors.initials: B
authors.lastname: Johnson
authors.forename: Cesar Misael
authors.initials: CM
authors.lastname: Gomez-Altamirano
authors.forename: Umesh
authors.initials: U
authors.lastname: Parashar
authors.forename: Manish
authors.initials: M
authors.lastname: Patel
mesh_terms: D017677:Age Distribution; D002675:Child, Preschool; D003968:Diarrhea, Infantile / Q000401:mortality* / Q000517:prevention & control; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D008800:Mexico / Q000453:epidemiology; D011159:Population Surveillance; D012400:Rotavirus Infections / Q000401:mortality / Q000517:prevention & control*; D022243:Rotavirus Vaccines
chemical_list: D022243:Rotavirus Vaccines